|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.920 AUD | +1.39% |
|
+2.46% | +11.45% |
| Capitalization | 33.58B 22.3B 19B 17.75B 16.7B 30.74B 2,020B 207B 80.35B 952B 83.68B 81.92B 3,474B | P/E ratio 2026 * |
46x | P/E ratio 2027 * | 38.3x |
|---|---|---|---|---|---|
| Enterprise value | 34.18B 22.7B 19.34B 18.06B 16.99B 31.29B 2,056B 211B 81.77B 969B 85.16B 83.37B 3,535B | EV / Sales 2026 * |
3.21x | EV / Sales 2027 * | 2.9x |
| Free-Float |
84.72% | Yield 2026 * |
1.34% | Yield 2027 * | 1.62% |
Last Transcript: Sigma Healthcare Limited
| 1 day | +1.39% | ||
| 1 week | +2.46% | ||
| Current month | +1.39% | ||
| 1 month | -4.89% | ||
| 3 months | -2.67% | ||
| 6 months | -10.15% |
| 1 week | 2.79 |  | 2.93 |
| 1 month | 2.74 | | 2.99 |
| Current year | 2.64 | | 3.32 |
| 1 year | 2.64 | | 3.32 |
| 3 years | 2.64 | | 3.32 |
| 5 years | 2.64 | | 3.32 |
| 10 years | 2.64 | | 3.32 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikesh Ramsunder
CEO | Chief Executive Officer | 54 | 2022-01-31 |
Richard Murray
DFI | Director of Finance/CFO | - | 2025-10-12 |
Martin Hawkins
CTO | Chief Tech/Sci/R&D Officer | - | 2019-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Sammells
CHM | Chairman | - | 2022-07-05 |
Vikesh Ramsunder
BRD | Director/Board Member | 54 | 2022-01-31 |
Neville Mitchell
BRD | Director/Board Member | 66 | 2023-02-01 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.39% | +2.46% | - | - | 22.3B | |
| -0.21% | +0.64% | +41.23% | +119.30% | 100B | |
| -0.07% | -0.33% | +67.81% | +153.23% | 47.09B | |
| +0.70% | -1.61% | +12.76% | -5.77% | 10.28B | |
| +1.35% | +0.84% | -16.97% | -9.21% | 8.55B | |
| +1.09% | -0.97% | -7.24% | +0.05% | 8.16B | |
| -0.18% | -3.17% | +3.98% | +57.87% | 6.49B | |
| +2.02% | +1.69% | +24.62% | +27.77% | 5.85B | |
| +0.88% | +3.96% | +13.37% | +54.86% | 3.62B | |
| -1.17% | -0.59% | -7.13% | -5.73% | 3.59B | |
| Average | +0.58% | +0.13% | +14.71% | +43.60% | 21.64B | |
| Weighted average by Cap. | +0.20% | +0.35% | +38.40% | +101.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.66B 7.08B 6.03B 5.63B 5.3B 9.76B 641B 65.75B 25.5B 302B 26.56B 26B 1,103B | 11.68B 7.76B 6.61B 6.17B 5.81B 10.69B 702B 72.04B 27.94B 331B 29.1B 28.49B 1,208B |
| Net income | 728M 484M 412M 385M 362M 667M 43.8B 4.49B 1.74B 20.65B 1.81B 1.78B 75.33B | 868M 576M 491M 459M 431M 794M 52.2B 5.35B 2.08B 24.6B 2.16B 2.12B 89.77B |
| Net Debt | 595M 395M 337M 315M 296M 545M 35.81B 3.67B 1.42B 16.88B 1.48B 1.45B 61.58B | 322M 214M 182M 170M 160M 295M 19.39B 1.99B 771M 9.14B 803M 786M 33.34B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-12 | 2.920 $ | +1.39% | 12,076,070 |
| 25-12-11 | 2.880 $ | +1.41% | 15,536,180 |
| 25-12-10 | 2.840 $ | -0.35% | 8,617,028 |
| 25-12-09 | 2.850 $ | +2.15% | 11,829,050 |
| 25-12-08 | 2.790 $ | -2.11% | 9,122,467 |
Delayed Quote Australian S.E., December 12, 2025 at 12:13 am EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Annual profits - Rate of surprise
- Stock Market
- Equities
- SIG Stock
Select your edition
All financial news and data tailored to specific country editions
